Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$303,392
New position
Shares Held
1,600
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,043
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names. AZN ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,600 | $303,392 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,392 | 1,600 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||